Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105592
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105592
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105592
Figure 4 Calibration curve for predicting the probability of diabetic peripheral neuropathy and type 2 diabetes mellitus.
A: Training cohort (TC) of diabetic peripheral neuropathy (DPN) patients and type 2 diabetes mellitus (T2DM) patients; B: TC of T2DM patients and normal controls; C: Validation cohort (VC) of DPN patients and T2DM patients; D: VC of T2DM patients and normal controls. AUC: Area under the curve; T2DM: Type 2 diabetes mellitus; DPN: Diabetic peripheral neuropathy; TC: Training cohort; VC: Validation cohort.
- Citation: Xu WS, Xing H, Wang QQ, Qi H, He JT, Jin T, Kan YP, Sun SY, Wang JY, Lin FQ. Identification and validation of serum amino acids as diagnostic biomarkers for diabetic peripheral neuropathy. World J Diabetes 2025; 16(6): 105592
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105592.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105592